Join
Live feed
·
PRReleasevia Quantisnow
Quoin Pharmaceuticals Ltd. logo

Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome

ByQuantisnow·Wall Street's wire, on your screen.
QNRX· Quoin Pharmaceuticals Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track QNRX (Quoin Pharmaceuticals Ltd.) and more on Quantisnow.